• SPX
  • $5,738.17
  • -0.13 %
  • -$7.20
  • DJI
  • $42,313.00
  • 0.33 %
  • $137.89
  • N225
  • $37,904.04
  • -4.83 %
  • -$1,925.45
  • FTSE
  • $8,320.76
  • 0.43 %
  • $35.85
  • IXIC
  • $18,119.59
  • -0.39 %
  • -$70.71
PolarityTE, Inc. (PTE) Stock Price, News & Analysis

PolarityTE, Inc. (PTE) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$0.23
Day's range
$0.25
50-day range
$0.2
Day's range
$0.75
  • Country: US
  • ISIN: US7310942070
52 wk range
$0.2
Day's range
$1.9
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -43.07
  • Piotroski Score 3.00
  • Grade Overweight
  • Symbol (PTE)
  • Company PolarityTE, Inc.
  • Price $0.24
  • Changes Percentage (-0.82%)
  • Change -$0
  • Day Low $0.23
  • Day High $0.25
  • Year High $1.90

PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

  • Last Earnings 01/06/2016
  • Ex-Dividend for 5/16 Dividend 01/19/2016
  • Dividend Payable N/A
  • Today N/A
  • Next Earnings (Estimated) 08/09/2023
  • Fiscal Year End N/A

  • Average Stock Price Target $1.00
  • High Stock Price Target $1.00
  • Low Stock Price Target $1.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.58
  • Trailing P/E Ratio -0.41551724137931
  • Forward P/E Ratio -0.41551724137931
  • P/E Growth -0.41551724137931
  • Net Income $10.21 M

Income Statement

Quarterly

Annual

Latest News of PTE

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.